Cameron urges wider NHS access to Alzheimer’s drugs

Health · First reported 9 Nov, 04:16 · Updated 04:58

Image: Wikimedia Commons · NASA Johnson Space Center · Public domain

Former prime minister David Cameron and dementia specialists are calling for wider NHS access to Alzheimer’s drugs, including medicines not currently available outside clinical trials. Cameron also called for a maximum 18-week wait for diagnosis; decisions on routine NHS use are made by NICE.

David Cameron has joined dementia specialists in calling for access to Alzheimer’s drugs that are not currently available on the NHS outside clinical trials.
Cameron also called for a maximum 18-week wait for an Alzheimer’s diagnosis.
The Times describes the appeal as a call by Cameron, experts and former health ministers for wider access to treatments that slow the disease.

Summary written by Lux AI from 2 articles

Key facts

Cameron’s role: President of Alzheimer’s Research UK.
Diagnosis-wait proposal: A maximum 18-week wait.
Reported licensing year: The medicines were licensed in 2024.
NHS availability: Not available outside clinical trials, according to The Independent.
Routine-use decisions: Made by the National Institute for Health and Care Excellence (NICE).